| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Allakos Inc (NASDAQ: ALLK)
ALLK Technical Analysis
5
| As on 9th Jun 2023 ALLK STOCK Price closed @ 4.80 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 6.55 & Strong Sell for SHORT-TERM with Stoploss of 12.68 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ALLKSTOCK Price
| Open | 4.87 | Change | Price | % |
| High | 4.93 | 1 Day | -0.05 | -1.03 |
| Low | 4.72 | 1 Week | 0.20 | 4.35 |
| Close | 4.80 | 1 Month | 0.54 | 12.68 |
| Volume | 598740 | 1 Year | -77.69 | -94.18 |
| 52 Week High 84.39 | 52 Week Low 2.60 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| ALLK Daily Charts |
ALLK Intraday Charts |
Whats New @ Bazaartrend |
ALLK Free Analysis |
|
|
ALLK Important Levels Intraday
| RESISTANCE | 5.20 |
| RESISTANCE | 5.07 |
| RESISTANCE | 4.99 |
| RESISTANCE | 4.91 |
| SUPPORT | 4.69 |
| SUPPORT | 4.61 |
| SUPPORT | 4.53 |
| SUPPORT | 4.40 |
ALLK Forecast April 2024
| 4th UP Forecast | 10.99 |
| 3rd UP Forecast | 9 |
| 2nd UP Forecast | 7.78 |
| 1st UP Forecast | 6.55 |
| 1st DOWN Forecast | 3.05 |
| 2nd DOWN Forecast | 1.82 |
| 3rd DOWN Forecast | 0.6 |
| 4th DOWN Forecast | -1.39 |
ALLK Weekly Forecast
| 4th UP Forecast | 11.14 |
| 3rd UP Forecast | 9.11 |
| 2nd UP Forecast | 7.85 |
| 1st UP Forecast | 6.59 |
| 1st DOWN Forecast | 3.01 |
| 2nd DOWN Forecast | 1.75 |
| 3rd DOWN Forecast | 0.49 |
| 4th DOWN Forecast | -1.54 |
ALLK Forecast2024
| 4th UP Forecast | 163.58 |
| 3rd UP Forecast | 112.66 |
| 2nd UP Forecast | 81.18 |
| 1st UP Forecast | 49.71 |
| 1st DOWN Forecast | -40.11 |
| 2nd DOWN Forecast | -71.58 |
| 3rd DOWN Forecast | -103.06 |
| 4th DOWN Forecast | -153.98 |
Allakos Inc ( NASDAQ USA Symbol : ALLK )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ALLK Business Profile
Allakos Inc. operates as a clinical stage biopharmaceutical company. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and/or eosinophilic duodenitis; and a Phase II/III study for the treatment of eosinophilic esophagitis. The is also developing lirentelimab (AK002) for the treatment of mast cell gastrointestinal disease, severe allergic conjunctivitis, chronic urticaria, and indolent systemic mastocytosis. Allakos Inc. was incorporated in 2012 and is headquartered in Redwood City, California. Address: 975 Island Drive, Redwood City, CA, United States, 94065
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service